BREAKTHROUGH ISOLAZ(TM) ACNE THERAPY FEATURED IN U.S. NEWS & WORLD REPORT:
Discussing clinical outcomes, the article explains the Isolaz(TM) system's
effectiveness on patients of all ages, who have struggled with acne and have
failed traditional therapies including topicals and antibiotics.
The article describes a 22-year-old patient's struggle with acne and her
100% clinical, emotional and functional improvement post Isolaz(TM)
treatments. Dermatologist
In addition to this breakthrough painless therapy for acne, Aesthera's Isolaz(TM) system is also FDA cleared to treat skin rejuvenation, including the treatment of vascular and pigmented lesions as well as hair removal on all skin types.
Prior to its coverage by U.S. News & World Report, Isolaz(TM) therapy has
also been recently featured in the New York Times and Wall Street Journal. It
has also been covered by Vogue, Elle, Allure, Shape, Bazaar, Self, and the
To learn where you can receive an Isolaz(TM) treatment or to receive more information on the Isolaz(TM) System please visit www.ISOLAZ.com.
About Aesthera Corporation
Aesthera (www.AESTHERA.com) develops, manufactures and markets light-based aesthetic treatment systems based on proprietary Photopneumatic(TM) (PPx(TM)) technology. Clinically proven to be pain-free and up to seven times faster than currently available light-based aesthetic systems, Aesthera's revolutionary systems combine the proven properties of therapeutic light with gentle pneumatic energy to more effectively work on dermal and epidermal skin targets.
SOURCE Aesthera Corporation
